NCT06237218 · RECRUITING

Effects of the COTID (Community Occupational Therapist in Dementia) Program and Usual Occupational Therapy Care on Recurrence of Falls at 12 Months in Elderly People With Neurocognitive Disorders Who Had Been Hospitalized for Falls, After Their Return Home

This trial is testing whether a structured home-based occupational therapy program called COTID reduces repeat falls over 12 months in people aged 75 and older with mild to moderate dementia who were recently hospitalized after a fall. An occupational therapist works with both the patient and their caregiver at home. This is a Phase NA pragmatic trial — it is comparing two care approaches rather than testing a new drug or device.

Eligibility criteria

Inclusion Criteria:
* Male or female, at least 75 years old
* Living at home (excluding nursing home or long-term care facilities)
* Hospitalized for fall
* Presenting major mild to moderate dementia (MMSE > 16)
* Accompanied by a caregiver with sufficient presence to meet study procedures: at investigator's discretion at the investigator's discretion
* Having given free, informed and written consent signed by the patient
* Whose caregiver has given free, informed consent written and signed by him/herself
* Affiliated or beneficiary of social security
Exclusion Criteria:
* With serious, life-threatening pathology(ies) or in palliative care
* Participating in an educational fall program on the theme of falls, run by an occupational therapist by an occupational therapist
* Receiving regular occupational therapy treatment on the day of inclusion (day care daily hospitalization)
* Participating in a clinical research protocol have an impact on the occurrence of a fall (at the investigator's discretion)
* Not matching with the fall definition from Kellogg's definition of a fall (loss of consciousness, sudden onset of paralysis paralysis or epileptic seizure)
* Presenting a very significant post-fall syndrome:
score of 4/4 on the "Get-up early" questionnaire
* unable to read or write
* Participant under legal guardianship (curator, guardian, legal protector)
* Dementia with rapid neurocognitive degeneration degeneration with frontal and language impairment (at the investigator's discretion).

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-01-14

View full record on ClinicalTrials.gov

All APOE4 clinical trials